NEW YORK (GenomeWeb) – Biocept said this morning that it received notification yesterday from the Nasdaq that it has regained compliance with the exchange's minimum bid listing requirement.

Nasdaq notified the company last November that it had failed to maintain the required $1 per share minimum bid price, and faced delisting if it did not regain compliance within a 180-day grace period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.